Metastatic brain tumor is a malignant formation that occurs as a result of migration of cancer cells from other organs, most often the lungs, breast, and colon. These tumors are secondary to the primary malignant process and can be presented as multiple or single lesions. Brain metastases can sarcoidose in various areas of the brain, which leads to instability of neurological functions and a strong progression of clinical symptoms. The main manifestations include headaches, unexplained weight loss, seizures, changes in psychoemotional state, and neurological deficits that seriously impair the patient's quality of life. Treatment requires a multifactorial approach, including chemotherapy, radiation therapy, and in some cases surgery.
History of the disease and interesting historical facts
The history of studying metastatic brain tumors goes back to the distant past. The first mentions of metastatic processes refer to the work of ancient doctors, such as Hippocrates, who described observations of cancerous formations. However, the systematic study of metastases began to actively develop in the 19th century, which is associated with the development of pathological anatomy and an increased understanding of the role of the lymphatic system in the spread of malignant tumors. In 1917, the Austrian neurologist Gustav Kolmogorov published a work on metastatic lesions of the central nervous system, which became fundamental for further research. In recent decades, special attention has been paid to the molecular genetics of malignant tumors, which allows for a more accurate understanding of the mechanisms of metastasis and the discovery of new approaches to therapy.
Epidemiology
Statistics show that metastatic brain tumors account for nearly 50% of all central nervous system tumors. In total, the U.S. Department of Health and Human Services estimates that about 200,000 new cases of metastatic brain tumors are diagnosed each year. The mortality rate of this disease is very high, with only 20% patients surviving more than a year after diagnosis. Most often, brain metastases develop in people between the ages of 40 and 70, with men being affected more often than women. Given demographic trends and the increase in cancer cases in general, the number of metastatic tumors is expected to increase.
Genetic predisposition to this disease
Genetic predisposition to metastatic brain tumors is being studied in the context of hereditary syndromes and mutations. It has been shown that alterations in the TP53, BRCA1, BRCA2 and EGFR genes can increase the risk of developing metastatic lesions. Genes responsible for angiogenesis and cell proliferation are also highlighted as important predisposition factors. In particular, mutations in the TP53 gene, known as the “signature gene of cancer”, can contribute to both primary tumor formation and its metastasis. The genetic pattern of the metastatic process remains a topic of active research in order to respectively refine target molecules for therapy.
Risk factors for the development of this disease
Risk factors for the development of metastatic brain tumors can be divided into several categories:
- Primary tumors: lung cancer, breast cancer, melanoma, lung cancer and kidney cancer have the highest probability of metastasizing to the brain.
- Genetic predisposition: Having a family history of cancer increases the risk of developing metastases.
- Age: The risk of developing cancer and metastasis increases with age.
- Gender: Men are more likely to suffer from brain metastases than women.
- Previous radiotherapy or chemotherapy treatments may increase the risk of metastatic formation by disrupting normal cell division protocols.
Diagnosis of this disease
Diagnosis of metastatic brain tumors includes several stages:
- Main symptoms: headaches, changes in vision, seizures, neurological disorders, changes in behavior and memory.
- Lab tests: Blood tests to detect cancer markers and the patient's overall health.
- Radiological examinations: MRI and CT of the brain are the main imaging methods. MRI provides more detailed images and helps to determine the number and location of metastases.
- Other diagnostics: PET-CT can be used to assess the metabolic activity of tumors.
- Differential diagnosis: Other causes of symptoms, such as infectious diseases, vascular processes or dementia, must be excluded.
Treatment
Treatment of metastatic brain tumors is usually complex and includes:
- General treatment: Strengthening therapy to increase the body's overall resistance, consider recommendations for diabetes and other concomitant diseases.
- Pharmacological treatment: Systemic therapy aims to reduce the size of tumors using chemotherapeutic agents and targeted drugs.
- Surgical treatment: surgery may be recommended in the presence of single metastases and clear localization, which will allow the removal of the metastasis and improve the quality of life.
- Other treatments: Radiotherapy (eg, stereotactic radiosurgery) plays an important role in controlling the growth of metastases.
List of medications used to treat this disease
The main drugs used to treat metastatic brain tumors include:
- Temozolomide
- Capecitabine
- Nivolumab
- Alectinab
- Lapatinib
- Vancomycin (to support a healthy immune system)
Disease monitoring
Monitoring of metastatic brain tumors is important to assess treatment efficacy and prognosis:
- Control stages: regular MRI to monitor tumor growth or shrinkage, blood tests to monitor general condition.
- Prognosis: Dependent on the primary source of cancer, the patient's general condition, and response to therapy. On average, 1-2 years after diagnosis.
- Complications: development of resistance to drug therapy, deterioration of neurological status.
Age-related features of the disease
Metastatic brain tumors may present differently depending on age group:
- In children: metastasis is quite rare, most often occurs with nephroblastoma cancer or lymphomas. Symptoms may be scanty, but dramatically worsen the quality of life.
- In young people: metastases from primary breast tumors and melanoma are often observed, with pronounced neurological symptoms appearing late.
- In elderly people: metastases from the lungs and intestines are more often detected, neurological disorders are more pronounced and mortality is high.
Questions and Answers
- What are the main symptoms of metastatic brain tumor? The most common symptoms are headaches, seizures, changes in vision and cognitive impairment.
- How is metastatic brain tumor diagnosed? The main diagnostic methods include MRI and CT scans, as well as laboratory tests to detect cancer markers.
- What is the life expectancy for metastatic brain tumors? The prognosis depends significantly on the primary cancer and the general condition of the patient; on average, survival after diagnosis is 1-2 years.
- What is the most common treatment for metastatic tumors? Treatment includes chemotherapy, radiotherapy and surgery, depending on the patient's condition.
- Are there risk factors that influence the development of metastatic tumors? Yes, this includes primary malignancies, genetic predisposition, age and gender.
